Human Monoclonal Antibody Combination against SARS Coronavirus: Synergy and Coverage of Escape Mutants
Research Article
[키워드] 2003
acute respiratory syndrome
Administered
affected
against SARS-CoV
Alter
Amino acid
anti-SARS-CoV antibody
antibody
antibody concentration
Antigen
antigens
approach
arising
Bacteria
binding
blocked
Blood
breadth
carried
caused
center
China
close contact
close person-to-person contact
Combination
complementary
Concentration
Control
convalescent SARS patient
coronavirus
Coverage
CR3014
CR3022
died
different
disease
disease severity
dose
Effect
effective
Epidemic
Epidemics
epitope
escape
experiment
feasible
ferret
ferrets
finding
generate
glycoprotein
Guangdong
Health
healthy
Hong Kong
Human
human cell
human cells
human macrophage
Human monoclonal antibody
humans
immune
Immune escape
immunization
immunize
in vitro
individual effects
Infected
infecting
Infection
infectious
Infectious disease
information
interact
Interaction
International
killing
Laboratory
less
limit
lung damage
Lung pathology
mAb
mAbs
measure
monoclonal
monoclonal antibody
Mutation
neutralization
neutralized
NO
organism
Patient
pharyngeal
Prevent
prevented
prevention
producing
Prophylaxis
provided
quarantine
recognize
recognizing
reduce
reduction
repeated
replicated
required
Research
researcher
residue
responsible
SARS epidemic
SARS-CoV
SARS-CoV infection
screened
shown
sick
Spread
strain
suppress
synergistic
synergistic fashion
synergy
tested
the disease
the receptor-binding domain
Travel
treat
variant
variants
viral escape
viral spread
virus
virus
Virus neutralization
virus strain
virus-neutralizing
viruses
website
Wikipedia
World Health Organization
[DOI] 10.1371/journal.pmed.0030237 PMC 바로가기 [Article Type] Research Article
[DOI] 10.1371/journal.pmed.0030237 PMC 바로가기 [Article Type] Research Article